KFAR SABA, Israel, Oct. 2nd, 2017 /PRNewswire/ — CathWorks Ltd., a leader in the development of non-invasive FFR measurements for guiding coronary interventions, today announced the completion of a $15.8M Series B round of financing, led by Quark Venture and Triventures. The syndicate also included Planven Investments, Pontifax, Corundum Open Innovation, and BioStar Venturesas well as a strategic investor. […]
Coronary/Structural Heart
Jeffrey H. Burbank Joins CryoLife Board of Directors
ATLANTA, Oct. 2, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced the appointment of Jeffrey H. Burbank to its Board of Directors effective September 29, 2017. Pat Mackin, Chairman, President, and Chief Executive Officer, commented, “Jeff has over 30 years of in-depth management […]
Essential Medical Completes Enrollment In US IDE Trial For The MANTA Large Bore Vascular Closure Device Used Primarily In Percutaneous Heart Valve Replacement Procedures
MALVERN, Pennsylvania, Oct. 2, 2017 /PRNewswire/ — Essential Medical today announced the completion of enrollment in the US pivotal IDE trial of the MANTA large bore vascular closure device. “Our team is thrilled with the enthusiasm of investigators and sites that accelerated MANTA study enrollment,” commented Todd Sorzano, Director of Operations at Essential […]
Boston Scientific victory upheld for stent
The Federal court upheld a previous coronary stent win over Dr. David Jang Appeals court upholds Boston Scientific win over stent pioneer Jang BY BRAD PERRIELLO, MassDevice A federal appeals court today upheld a Boston Scientific (NYSE:BSX) win over coronary stent pioneer Dr. David Jang. The case dates back to 1999, when Jang won […]
CHF Solutions Initiates International Distribution with UK-Based APC Cardiovascular Ltd.
EDEN PRAIRIE, Minn., Sept. 28, 2017 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS) announced today that it is initiating international distribution of its products by entering into a distribution agreement with APC Cardiovascular Ltd., a distributor based in the United Kingdom. APC Cardiovascular will market CHF Solutions’ Aquadex FlexFlow® System and will serve as CHF Solutions authorized service provider […]
Medtronic HeartWare(TM) HVAD(TM) System Approved for Destination Therapy
DUBLIN – September 27, 2017 – Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients with advanced heart failure who are not candidates for heart transplants. The HVAD System, a left ventricular assist device or LVAD, […]
Abiomed (ABMD) Gets in on Magenta Medical’s $15 Million Funding Round
TEL-AVIV, Israel, September 28, 2017 /PRNewswire/ — Magenta Medical, a medical device company in the field of transcatheter heart failure therapy, announced today the successful closing of its $15M series B financing round. The syndicate of investors is comprised of Abiomed Inc., a leader in transcatheter heart pumps, Pitango Venture Capital, among Israel’s leading venture capital […]
Analytics 4 Life Raises $25 Million in Series B Financing to Advance its Artificial Intelligence-Backed Cardiac Imaging Technology
RESEARCH TRIANGLE PARK, NC and TORONTO, CANADA, September 27, 2017 — Analytics 4 Life, a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways, today announced it has completed a $25 million Series B financing. This unique financing event was supported by an […]
Corindus Announces Opening of First International Robotic Training Center
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today the opening of the first international CorPath GRX Robotic Center in Tokyo, Japan. Earlier this year, Corindus partnered with Japan Medicalnext Co., Ltd., a wholly-owned entity of MC Healthcare, Inc. (subsidiary of […]
BioCardia Announces Successful Interim Safety Analysis In Its Phase III Clinical Trial Of Cardiamp Stem Cell Therapy For Heart Failure
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent Data Safety Monitoring Board (DSMB) has completed the pre-specified interim analysis of safety outcomes for the first 10 patients treated in the Phase 3 trial of its […]



